Ethynylestradiol increases expression and activity of rat liver MRP3

Drug Metabolism and Disposition

Volumn 34, Issue 6, 2006, Pages 1030-1034

  Ruiz, María L ^a   Villanueva, Silvina S M ^a   Luquita, Marcelo G ^a   Vore, Mary ^b   Mottino, Aldo D ^a   Catania, Viviana A ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PARACETAMOL; PARACETAMOL GLUCURONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG EXCRETION; DRUG LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION; WESTERN BLOTTING;

ACETAMINOPHEN; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE; ETHINYL ESTRADIOL; LIVER; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PERFUSION; RATS; RATS, WISTAR; TIME FACTORS; UP-REGULATION;

ANIMALIA;

EID: 33646801665     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.009316     Document Type: Article

References (40)

1. Akita H, Suzuki H, and Sugiyama Y (2002) Sinusoidal efflux of taurocholate correlates with the hepatic expression level of Mrp3. Biochem Biophys Res Commun 299:681-687.
2. Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V, Chen Z-S, Grinberg A, Westphal H, Klein-Szanto A, et al. (2005) Analysis of the in vivo functions of Mrp3. Mol Pharmacol 68:160-168.
3. Bossard R, Stieger B, O'Neill B, Fricker G, and Meier P (1993) Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Investig 91:2714-2720.
4. Bridges RS (1984) A quantitative analysis of the roles of dosage, sequence and duration of estradiol and progesterone exposure in the regulation of maternal behavior in the rat. Endocrinology 114:930-940.
5. Cao J, Stieger B, Meier PJ, and Vore M (2002) Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol 283:G757-G766.
6. Carreras FI, Gradilone SA, Mazzone A, García F, Huang BQ, Ochoa JE, Tietz PS, LaRusso NF, Calamita G, and Marinelli RA (2003) Rat hepatocyte aquaporin-8 water channels are downregulated in extrahepatic cholestasis. Hepatology 37:1026-1033.
7. Catania VA, Luquita MG, Sánchez Pozzi EJ, and Mottino AD (1998) Enhancement of intestinal UDP-glucuronosyltransferase activity in partially hepatectomized rats. Biochim Biophys Acta 1380:345-353.
8. Cherrington NJ, Hartley DP, Li N, Johnson DR, and Klaassen CD (2002) Organ distribution of multidrug resistance proteins 1, 2 and 3 (Mrp1, 2 and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300:97-104.
9. Chu X, Strauss JR, Mariano MA, Li J, Newton DJ, Cai X, Wang RW, Yabut J, Hartley DP, Evans DC, et al. (2006) Characterization of mice lacking the multidrug resistance protein Mrp2 (Abcc2). J Pharmacol Exp Ther, in press.
10. Crocenzi FA, Sánchez Pozzi EJ, Pellegrino JM, Favre CO, Rodríguez Garay EA, Mottino AD, Coleman R, and Roma MG (2001) Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Hepatology 34:329-339.
11. Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, and Boyer JL (2004) Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 40:585-591.
12. Donner MG and Keppler D (2001) Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34:351-359.
13. Ghanem CI, Ruiz ML, Villanueva SSM, Luquita MG, Catania VA, Jones B, Bengochea LA, Vore M, and Mottino AD (2005) Shift from biliary to urinary elimination of acetaminophenglucuronide in acetaminophen-pretreated rats. J Pharmacol Exp Ther 315:987-995.
14. Hirohashi T, Ito K, Ogawa K, Suzuki H, Kume K, Shimizu T, and Sugiyama Y (1998) Hepatic expression of multidrug resistance-associated protein (MRP)-like proteins maintained in Eisai hyperbilirubinemic rats (EHBR). Mol Pharmacol 53:1068-1075.
15. Howie D, Adriaenssens PI, and Prescott LF (1977) Paracetamol metabolism following overdosage: application of high performance liquid chromatography. J Pharm Pharmacol 29:235-237.
16. Ikushiro S, Emi Y, and Iyanagi T (1995) Identification and analysis of drug responsive expression of UDP-glucuronosyltransferase family 1 (UGT1) isozyme in rat hepatic microsomes using anti-peptide antibodies. Arch Biochem Biophys 324:267-272.
17. Johnson BM, Zhang P, Schuetz JD, and Brouwer KL (2005) Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats. Drug Metab Dispos 34:556-562.
18. Kamisako T and Ogawa H (2005) Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis. J Gastroenterol Hepatol 20:1429-1434.
19. Kessler FK, Kessler MR, Auyeung DJ, and Ritter JK (2002) Glucuronidation of acetaminophen catalyzed by multiple rat phenol UDP-glucuronosyltransferases. Drug Metab Dispos 30:324-330.
20. König J, Rost D, Cui Y, and Keppler D (1999) Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29:1156-1163.
21. Koopen NR, Post SM, Wolters H, Havinga R, Stellaard F, Boverhof R, Kuipers F, and Princen HMG (1999) Differential effects of 17α- ethinylestradiol on the neutral and acidic pathway of bile salt synthesis in the rat. J Lipid Res 40:100-108.
22. Koopen NR, Wolters H, Havinga R, Vonk RJ, Jansen PLM, Müller M, and Kuipers F (1998) Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat. Hepatology 27:537-545.
23. Kroemer HK and Klotz U (1992) Glucuronidation of drugs: a re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 23:292-310.
24. Kullak-Ublick GA, Beuers U, and Paumgartner G (2000) Hepatobiliary transport. J Hepatol 32:3-18.
25. Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, and Boyer JL (2000) Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118:163-172.
26. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
27. Luquita MG, Catania VA, Sánchez Pozzi EJ, Veggi LM, Hoffman T, Pellegrino JM, Ikushiro S, Emi Y, Iyanagi T, Vore M, et al. (2001) Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver. J Pharmacol Exp Ther 298:49-56.
28. Manautou JE, De Waart DR, Kunne C, Zelcer N, Goedken M, Borst P, and Oude Elferink RPJ (2004) Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology 42:1091-1098.
29. Micheline D, Emmanuel J, and Serge E (2002) Effect of ursodeoxycholic acid on the expression of the hepatocellular bile acid transporters (Ntcp and Bsep) in rats with estrogen-induced cholestasis. J Pediatr Gastroenterol Nutr 35:185-191.
30. Mottino AD, Veggi LM, Wood M, Vélez Román J, and Vore M (2003) Biliary secretion of glutathione in estradiol-17β-D-glucuronide- induced cholestasis. J Pharmacol Exp Ther 307:306-313.
31. Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K, Akizawa T, Yoshioka M, and Sugiyama Y (2000) Characterization of inducible nature of MRP3 in rat liver. Am J Physiol 278:G438-G446.
32. Ruiz ML, Villanueva SSM, Luquita MG, Sánchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Ochoa JE, Vore M, Mottino AD, and Catania VA (2005) Mechanisms involved in spironolactoneinduced choleresis in the rat. Role of multidrug resistance-associated protein 2. Biochem Pharmacol 69:531-539.
33. Sánchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Rodríguez Garay EA, and Mottino AD (2003) Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. J Pharmacol Exp Ther 306: 279-286.
34. Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, and Sutherland E (1996) Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 271:G1043-G1052.
35. Slitt AL, Cherrington NJ, Naher JM, and Klaassen KD (2003) Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metab Dispos 31:1176-1186.
36. Soroka CJ, Lee JM, Azzaroli F, and Boyer JL (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783-791.
37. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, and Boyer JL (1997) The rat canalicular conjugate export pump (mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113:255-264.
38. Xiong H, Suzuki H, Sugiyama Y, Meier PJ, Pollack GM, and Brouwer KL (2002) Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment. Drug Metab Dispos 30:962-969.
39. Xiong H, Turne KC, Ward ES, Jansen PLM, and Brouwer KL (2000) Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats. J Pharmacol Exp Ther 295:512-518.
40. Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, and Borst P (2003) Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J 371:361-367.